Universal Cells Inc. is a private biotechnology company based in Seattle, Washington that is enabling the field of regenerative medicine by creating stem cells that are universally compatible. Its technology is based on intellectual property (IP) in-licensed from the University of Washington and includes methods for genome editing in human stem cells via homologous recombination with recombinant adeno-associated virus (rAAV) vectors, as well as specific HLA-engineering strategies.
I had the honor to interview Gregory Block, VP of Business Development for Universal Cells. Universal Cells is a private biotechnology company based in Seattle, Washington, that is revolutionizing the stem cell field by creating stem cells that are universally compatible.
